tirzepatide discontinued Why Is Not Working for Me? Common Causes Explained This dual FDA Announces End To Compounded
Description
Quick Facts: Higher doses (e.g., semaglutide 7.2 mg) showed up to 25% weight loss in trials

Anxiety has dogged me for years
Journal reference: Deanfield J, Verma S, Scirica BM, et al

Pregnant or breastfeeding women, people with copper metabolism disorders like Wilsons disease, and anyone with active skin infections should speak with a doctor before starting

( Wegovy , a semaglutide that is approved for weight loss, has already established such a registry.) In the scientific literature, theres at least one such retrospective case of a woman who didnt know she was pregnant taking semaglutide up until about the fourth week of her pregnancy
The active compound is tirzepatide, a synthetic peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R)
